XML 49 R34.htm IDEA: XBRL DOCUMENT v3.25.4

Revenue (Tables)

12 Months Ended

Dec. 31, 2025

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue [Table Text Block]

The following table represents our revenues disaggregated by product line (in thousands) and our disaggregated product line revenue as a percentage of total revenue:

			Year ended December 31,
			2025												2024												2023
Product line			Revenue						% of Revenue						Revenue						% of Revenue						Revenue						% of Revenue
Consumables			$	1,109,130					50		%				$	1,038,869					44		%				$	969,129					43		%
Infusion Systems			684,208						31		%				652,410						27		%				629,043						28		%
Vital Care			437,924						19		%				690,767						29		%				660,954						29		%
Total Revenues			$	2,231,262					100		%				$	2,382,046					100		%				$	2,259,126					100		%

We report revenue on a "where sold" basis, which reflects the revenue within the country or region in which the ultimate sale is made to our external customer.    

The following table represents our revenues disaggregated by geography (in thousands):

			Year ended December 31,
Geography			2025						2024						2023
United States			$	1,356,114					$	1,532,104					$	1,440,017
Europe, the Middle East and Africa			411,684						393,530						373,571
Asia-Pacific			232,903						232,820						241,699
Other Foreign			230,561						223,592						203,839
Total Revenues			$	2,231,262					$	2,382,046					$	2,259,126

Domestic sales accounted for 61%, 64% and 64% of total revenue in 2025, 2024 and 2023, respectively. International sales accounted for 39%, 36% and 36% of total revenue in 2025, 2024 and 2023, respectively.

Contract with Customer, Asset and Liability [Table Text Block]

Our contract balances (deferred revenue) are recorded in accrued liabilities and other long-term liabilities in our consolidated balance sheet (see Note 11: Accrued Liabilities). The following table presents the changes in our contract balances for the years ended December 31, 2024 and 2023, (in thousands):

			Contract Liabilities
Beginning balance, January 1, 2024			$	42,177
Equipment revenue recognized			(56,182)
Equipment revenue deferred due to implementation			55,932
Software revenue recognized			(28,292)
Software revenue deferred due to implementation			29,913
Government grant income recognized(1)			(2,072)
Government grant income deferred			—
Other deferred revenue recognized			(2,576)
Other deferred revenue			503
Ending balance, December 31, 2024			39,403
Equipment revenue recognized			(65,792)
Equipment revenue deferred due to implementation			74,836
Software revenue recognized			(35,715)
Software revenue deferred due to implementation			31,373
Government grant income recognized(1)			(2,066)
Government grant income deferred			—
Other deferred revenue recognized			(1,983)
Other deferred revenue			1,177
Ending balance, December 31, 2025			$	41,233

Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction

As of December 31, 2025, revenue from remaining performance obligations is as follows (in thousands):

			Recognition Timing
			<12 Months						> 12 Months
Equipment revenue			$	24,530					$	372
Software revenue			6,361						1,719
Government grant deferred income(1)			2,064						5,277
Other deferred revenue(2)			888						22
Total			$	33,843					$	7,390

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of expected timing for satisfying remaining performance obligation.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(1)
-SubTopic 10
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-13

+ Details

Name:	us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration